Wegovy Safety Guide

Wegovy side effects: what the data actually shows

By Iacob Pastina · Independent Researcher · Updated May 2026

The most common Wegovy side effects are gastrointestinal: nausea (44%), diarrhea (30%), vomiting (24%), and constipation (24%). 98.1% of GI side effects in the STEP-1 trial were mild to moderate, peaked during dose escalation (weeks 2-8), and improved over time. All percentages below come from the FDA-approved Wegovy prescribing information — not marketing materials.

Call your doctor or 911 immediately if you experience:

• Severe upper abdominal pain radiating to the back (possible pancreatitis — call 911)
• Difficulty breathing, throat swelling, or widespread hives (call 911)
• Inability to keep fluids down for 24+ hours (kidney-injury risk — call your provider or ER)
• Sharp upper-right pain after fatty meals with fever or jaundice (gallbladder — provider call)
• New or worsening suicidal thoughts (call your provider AND 988)

Report any serious adverse event to FDA MedWatch.

Common side effects: rates from the Wegovy label

Source: FDA-approved prescribing information for Wegovy (semaglutide 2.4mg), based on the STEP-1 trial published in NEJM (2021).

Side effect	Rate	Severity	When it peaks
Nausea	44%	Mild to moderate	Weeks 2-4 (during dose escalation)
Diarrhea	30%	Mild to moderate	Weeks 1-4
Vomiting	24%	Mild to moderate	Weeks 2-4
Constipation	24%	Mild	Weeks 4-12 (more common with food intake reduction)
Abdominal pain	20%	Mild cramping (severe pain is a red flag)	Weeks 1-4
Headache	14%	Mild	Weeks 1-2
Fatigue	11%	Mild	Weeks 1-4
Dyspepsia (indigestion)	9%	Mild	Throughout treatment
Dizziness	8%	Mild	Weeks 1-2
Hair loss (telogen effluvium)	3%	Cosmetic — temporary	Months 3-6 (related to rapid weight loss, not the drug directly)

What to expect, week by week

Wegovy uses a 16-week dose-escalation schedule from 0.25mg to the maintenance dose of 2.4mg. Most side effects cluster around dose changes and improve as your body adjusts.

Week 1 (0.25mg)

What's typical: Mild nausea (10-20% of patients), occasional headache, possible early appetite reduction. Most users report feeling 'a little off' but functional.

Red flags: Persistent vomiting, severe abdominal pain, allergic reaction symptoms.

Weeks 2-4 (0.5mg)

What's typical: Nausea peaks for many users (44% baseline). Diarrhea or constipation common. Appetite suppression more pronounced.

Red flags: Inability to keep fluids down for 24+ hours, severe upper abdominal pain radiating to back, fever.

Weeks 5-8 (1.0mg)

What's typical: GI symptoms typically improving. Weight loss usually 4-7% of baseline by this point. Some users plateau briefly during titration.

Red flags: Worsening symptoms instead of improving — discuss dose adjustment with your provider before escalating to 1.7mg.

Weeks 9-16 (1.7mg)

What's typical: Most users tolerate steady-state better than escalation. Continued weight loss. Hair shedding (telogen effluvium) may begin around month 3-4 in some users.

Red flags: New or worsening upper-right abdominal pain (gallbladder), severe fatigue with low urine output (kidney).

Weeks 17+ (2.4mg maintenance)

What's typical: Maintenance dose. STEP-1 trial showed 14.9% average weight loss at 68 weeks. GI symptoms minimal for most users by this point.

Red flags: Any new symptom that emerges months into treatment warrants a provider call — late-onset pancreatitis and gallbladder issues do occur.

Management protocols for the most common side effects

Nausea (44% of patients)

• Eat smaller, more frequent meals (5-6 small instead of 3 large)
• Avoid fatty, fried, spicy, or highly aromatic foods during dose escalation
• Stay hydrated with small sips throughout the day; ginger or peppermint tea helps many users
• Take Wegovy on the same day each week — your provider may suggest a day before a low-stress evening
• Most providers will hold dose escalation for 2-4 weeks if nausea is intolerable rather than push to the next dose

Diarrhea (30%) and Vomiting (24%)

• Maintain hydration as the priority — water plus electrolytes (sports drinks, oral rehydration salts)
• BRAT diet (bananas, rice, applesauce, toast) for diarrhea
• Avoid caffeine, alcohol, and dairy during acute symptoms
• If you cannot keep fluids down for 24 hours, call your provider — risk of dehydration-induced kidney injury

Constipation (24%)

• Increase fiber gradually (25-30g/day) — too much too fast worsens GI symptoms
• Drink at least 64oz of water daily, more if active
• Walking 30 minutes daily helps gut motility
• OTC stool softeners (docusate) are safe for short-term use; check with provider before laxatives
• Persistent constipation past 1 week with abdominal distension warrants a provider call

Hair shedding (3% report it)

• This is telogen effluvium — caused by rapid weight loss, not the drug acting on hair follicles directly
• Ensure 60-80g/day of protein intake (this is harder than it sounds when appetite is suppressed)
• Consider biotin and iron supplementation if levels are low (test before supplementing)
• Regrowth typically begins 3-6 months after weight stabilizes

Serious side effects — recognize these red flags

Rare but serious. Knowing the warning signs is the difference between a manageable problem and an emergency.

Pancreatitis

<0.5% (rare but serious)

Red-flag symptoms: Severe upper abdominal pain radiating to the back, with persistent nausea or vomiting

Action: STOP Wegovy and seek emergency care immediately. Do not restart without provider clearance.

Gallbladder problems

1.6% (gallstones), 0.6% (cholecystitis)

Red-flag symptoms: Sharp upper-right abdominal pain after fatty meals, fever, jaundice

Action: Contact your provider for imaging. May require surgical removal in 0.5-1% of cases.

Kidney injury (acute)

Rare

Red-flag symptoms: Decreased urine output, swelling, fatigue — usually after persistent vomiting or diarrhea causing dehydration

Action: Maintain aggressive hydration during GI symptoms. If you cannot keep fluids down for 24 hours, contact your provider or ER.

Hypoglycemia

Variable — primarily in patients also taking insulin or sulfonylureas

Red-flag symptoms: Shakiness, sweating, confusion, rapid heartbeat, blurred vision

Action: Treat immediately with 15g fast-acting carbs (juice, glucose tablets). Recheck in 15 minutes. Discuss insulin dose reduction with your prescriber if recurring.

Severe allergic reaction (anaphylaxis)

Rare (<0.1%)

Red-flag symptoms: Difficulty breathing, throat or facial swelling, widespread hives, drop in blood pressure

Action: CALL 911. Do not drive yourself.

Suicidal ideation

Under FDA post-marketing review — no causal link established

Red-flag symptoms: New or worsening depression, mood changes, self-harm thoughts

Action: Contact your provider AND report to FDA MedWatch (1-800-FDA-1088). The 988 Suicide & Crisis Lifeline is available 24/7.

The boxed warning: thyroid C-cell tumors

Wegovy carries a boxed warning— the FDA's strongest warning level — for thyroid C-cell tumors. This is based on rodent studies; no causal link has been established in humans.

Wegovy is contraindicated in patients with:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

Your prescriber should screen for these before initiating Wegovy. If a telehealth provider does not ask about thyroid history during intake, treat that as a quality flag — programs with stronger clinical oversight (board-certified obesity medicine physicians, comprehensive intake) catch this systematically.

Choosing a provider who handles side effects well

Wegovy is a long-term medication. The difference between a good and mediocre telehealth program shows up exactly when side effects appear: does the provider respond within hours or days? Will they hold dose escalation if you're struggling, or push you to the next dose? Are quarterly labs included to catch kidney or liver changes early?

Among the 48 GLP-1 telehealth providers we track, Eden Health (8.9/10) is our highest-rated for medical oversight: board-certified obesity medicine physicians, quarterly blood panels included, and a published protocol for dose-hold during intolerable side effects. For comprehensive support during the first 16 weeks (when most side effects cluster), this matters more than the price difference.

See how all 48 providers score on clinical oversight in the full rankings, or take the 60-second match quiz to find providers that fit your support needs.

Zepbound side effects deep dive — for users comparing the two
Cross-drug GLP-1 side effects comparison — Wegovy vs Zepbound vs Foundayo vs Rybelsus rates side-by-side
Wegovy vs Zepbound: cost, side effects, and weight loss
FDA warning letter tracker — 50+ enforcement actions against GLP-1 providers since 2025
Provider safety checker — verify any GLP-1 telehealth program before enrolling

Sources

This page is for informational purposes only and is not medical advice. Always discuss medication decisions with a licensed prescriber. Side-effect rates are population averages from clinical trials and may not reflect your individual experience. If you are experiencing a medical emergency, call 911.